silver has been researched along with nystatin a1 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Arnaud, P; Azar, M; Malbrunot, C; Vermerie, N | 1 |
Azeredo, J; Barbosa, DB; Camargo, ER; Gorup, LF; Henriques, M; Monteiro, DR; Negri, M; Oliveira, R; Pires, P; Silva, S; Williams, DW | 1 |
Barbosa, DB; de Camargo, ER; Gorup, LF; Henriques, M; Monteiro, DR; Negri, M; Oliveira, R; Silva, S | 1 |
Anwar, A; Khan, NA; Rajendran, K; Siddiqui, R | 1 |
Ahmed, D; Anwar, A; Hussain, MA; Khan, NA; Shah, MR; Siddiqui, R | 1 |
Ahmed, D; Ahmed, S; Anis, I; Anwar, A; Hussain, MA; Khan, NA; Perveen, S; Shah, MR | 1 |
Alves, MM; Barbosa, DB; Delbem, ACB; Figueiral, MH; Lopes, MM; Mira, NP; Pinto, E; Souza, JAS | 1 |
Aftab, S; Ashraf, A; El-Marghany, A; Gill, KA; Khan, MI; Manzoor, S; Raza, H; Raza, N; Shakeel, N; Shamim, R; Sohail, Y | 1 |
8 other study(ies) available for silver and nystatin a1
Article | Year |
---|---|
Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity.
Topics: Antifungal Agents; Colloids; Drug Combinations; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mouthwashes; Nystatin; Silver; Suspensions; Temperature; Time Factors | 1997 |
The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Topics: Acrylic Resins; Adhesiveness; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Colony Count, Microbial; Microscopy, Electron, Scanning; Nanoparticles; Nystatin; Silver | 2013 |
Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
Topics: Antisepsis; Biofilms; Candida albicans; Candida glabrata; Chlorhexidine; Colony Count, Microbial; Disinfectants; Drug Synergism; Humans; Microscopy, Electron, Scanning; Nanoparticles; Nystatin; Silver; Spectrophotometry | 2013 |
Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
Topics: Amebicides; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fluconazole; Metal Nanoparticles; Naegleria fowleri; Nanocapsules; Nanoconjugates; Nystatin; Particle Size; Silver; Survival Rate; Treatment Outcome | 2017 |
Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Fluconazole; Humans; Metal Nanoparticles; Microscopy, Atomic Force; Nystatin; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2018 |
Combination Therapy of Clinically Approved Antifungal Drugs Is Enhanced by Conjugation with Silver Nanoparticles.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Drug Synergism; Fluconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nystatin; Silver; Surface Properties | 2019 |
Study of the activity of Punica granatum-mediated silver nanoparticles against Candida albicans and Candida glabrata, alone or in combination with azoles or polyenes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida glabrata; Fluconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Nystatin; Polyenes; Pomegranate; Silver | 2020 |
Synthesis and characterization of Hyaluronic Acid (HA) modified polymeric composite for effective treatment of wound healing by transdermal drug delivery system (TDDS).
Topics: Animals; Drug Delivery Systems; Hyaluronic Acid; Metal Nanoparticles; Mice; Nystatin; Silver; Wound Healing | 2023 |